Cervomed Inc. (CRVO) — 8-K Filings

8-K Filings (44)

• CervoMed Inc. Files 8-K with Regulatory Updates — Dec 5, 2025 Risk: low
  CervoMed Inc. filed an 8-K on December 5, 2025, reporting on events that occurred on December 1, 2025. The filing includes information related to Regulation FD
• CervoMed Inc. Files 8-K on Financials — Nov 10, 2025 Risk: low
  CervoMed Inc. filed an 8-K on November 10, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements a
• 8-K Filing — Nov 4, 2025
• CervoMed Inc. Announces Board Changes and Officer Appointments — Oct 29, 2025 Risk: medium
  CervoMed Inc. announced on October 27, 2025, a change in its board of directors, with the election of new directors and the appointment of certain officers. The
• CervoMed Inc. Files 8-K: Reg FD Disclosure & Exhibits — Oct 22, 2025 Risk: low
  CervoMed Inc. filed an 8-K on October 22, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Diffu
• CervoMed Inc. Files 8-K with Regulatory Updates — Oct 8, 2025 Risk: low
  CervoMed Inc. filed an 8-K on October 8, 2025, reporting on events including a Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. Th
• CervoMed Inc. Files 8-K on Financials — Aug 11, 2025 Risk: low
  CervoMed Inc. filed an 8-K on August 11, 2025, reporting on its Results of Operations and Financial Condition. The filing includes financial statements and exhi
• CervoMed Inc. Files 8-K: Regulation FD & Financials — Aug 5, 2025 Risk: low
  CervoMed Inc. filed an 8-K on August 5, 2025, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Diff
• CervoMed Inc. Files 8-K — Jul 28, 2025 Risk: low
  CervoMed Inc. filed an 8-K on July 28, 2025, reporting on other events and financial statements. The company, formerly known as Diffusion Pharmaceuticals Inc.,
• CervoMed Inc. Files 8-K on Shareholder Votes & Financials — Jun 25, 2025 Risk: low
  CervoMed Inc. filed an 8-K on June 25, 2025, reporting on matters submitted to a vote of security holders and financial statements. The company, formerly known
• CervoMed Inc. Files 8-K with Regulatory Updates — May 19, 2025 Risk: low
  CervoMed Inc. filed an 8-K on May 19, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Diffusion
• CervoMed Inc. Reports Material Agreements and Officer Changes — Apr 18, 2025 Risk: medium
  CervoMed Inc. filed an 8-K on April 18, 2025, reporting on several key events that occurred on April 14, 2025. These include entering into a material definitive
• CervoMed Inc. Files 8-K with Regulatory Updates — Apr 7, 2025 Risk: low
  CervoMed Inc. filed an 8-K on April 7, 2025, reporting events that occurred on April 2, 2025. The filing includes information related to Regulation FD Disclosur
• CervoMed Inc. Files 8-K on Financials — Mar 18, 2025 Risk: low
  CervoMed Inc. filed an 8-K on March 18, 2025, reporting on its results of operations and financial condition as of March 17, 2025. The filing includes financial
• CervoMed Inc. Files 8-K for Regulation FD Disclosure — Mar 11, 2025 Risk: low
  CervoMed Inc. filed an 8-K on March 11, 2025, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or material events be
• CervoMed Inc. Files 8-K — Mar 10, 2025 Risk: low
  CervoMed Inc. filed an 8-K on March 10, 2025, reporting on other events and financial statements. The company, formerly known as Diffusion Pharmaceuticals Inc.,
• CervoMed Inc. Files 8-K — Jan 31, 2025 Risk: low
  CervoMed Inc. filed an 8-K on January 31, 2025, reporting on other events and financial statements. The company, formerly known as Diffusion Pharmaceuticals Inc
• CervoMed Inc. Files 8-K — Dec 10, 2024 Risk: low
  CervoMed Inc. filed an 8-K on December 10, 2024, reporting on other events and financial statements. The company, formerly known as Diffusion Pharmaceuticals In
• CervoMed Inc. Files 8-K with Regulatory Updates — Dec 3, 2024 Risk: low
  CervoMed Inc. filed an 8-K on December 3, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Diffu
• CervoMed Inc. Files 8-K — Nov 27, 2024 Risk: low
  CervoMed Inc. filed an 8-K on November 27, 2024, reporting other events and financial statements. The company, formerly known as Diffusion Pharmaceuticals Inc.,
• CervoMed Inc. to be Acquired for $11.5 Million — Nov 13, 2024 Risk: medium
  CervoMed Inc. announced on November 8, 2024, that it has entered into a definitive agreement to be acquired by an unaffiliated third party for $1.00 per share i
• CervoMed Inc. Files 8-K — Nov 4, 2024 Risk: low
  CervoMed Inc. filed an 8-K on November 4, 2024, reporting other events and financial statements. The company, formerly known as Diffusion Pharmaceuticals Inc.,
• CervoMed Inc. Files 8-K Report — Oct 30, 2024 Risk: low
  On October 29, 2024, CervoMed Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulatio
• CervoMed Inc. Files 8-K: Other Events & Financials — Oct 16, 2024 Risk: medium
  CervoMed Inc. filed an 8-K on October 15, 2024, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific details a
• CervoMed Inc. Terminates Material Definitive Agreement — Oct 3, 2024 Risk: medium
  CervoMed Inc. announced on October 1, 2024, the termination of a material definitive agreement. The company, formerly known as Diffusion Pharmaceuticals Inc., i
• CervoMed Inc. Files 8-K: Other Events & Exhibits — Oct 1, 2024 Risk: low
  CervoMed Inc. filed an 8-K on October 1, 2024, reporting on events that occurred on September 26, 2024. The filing is categorized under 'Other Events' and 'Fina
• CervoMed Inc. Files 8-K on Financials — Aug 15, 2024 Risk: low
  CervoMed Inc. filed an 8-K on August 15, 2024, reporting on its results of operations and financial condition as of August 12, 2024. The filing also included Re
• CervoMed to Acquire NeuroVasc for $10M — Aug 1, 2024 Risk: medium
  CervoMed Inc. announced on July 29, 2024, that it has entered into a definitive agreement to acquire all outstanding shares of common stock of NeuroVasc Inc. fo
• CervoMed Inc. Files 8-K — Jul 23, 2024 Risk: low
  CervoMed Inc. filed an 8-K on July 23, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific fi
• CervoMed Inc. Files 8-K — Jul 12, 2024 Risk: low
  CervoMed Inc. filed an 8-K on July 12, 2024, reporting other events and financial statements. The company, formerly known as Diffusion Pharmaceuticals Inc., Res
• CervoMed Inc. to be Acquired — Jun 14, 2024 Risk: medium
  CervoMed Inc. announced on June 11, 2024, that it has entered into a definitive agreement to be acquired by an unaffiliated third party. The transaction is expe
• CervoMed Inc. Reports Executive Changes and Agreement Termination — May 20, 2024 Risk: medium
  CervoMed Inc. announced on May 17, 2024, the termination of a material definitive agreement. The company also reported the departure of directors or certain off
• CervoMed Inc. Files 8-K on Financials — May 15, 2024 Risk: low
  CervoMed Inc. filed an 8-K on May 15, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibit
• CervoMed Inc. Files 8-K with Regulatory Updates — Apr 23, 2024 Risk: low
  CervoMed Inc. filed an 8-K on April 23, 2024, reporting on events as of April 22, 2024. The filing includes information related to Regulation FD Disclosure, Oth
• CervoMed Inc. Files 8-K on Financials — Apr 5, 2024 Risk: low
  CervoMed Inc. filed an 8-K on April 5, 2024, reporting on its results of operations and financial condition as of April 1, 2024. The filing includes financial s
• CervoMed Inc. Files 8-K: Regulation FD & Financials — Apr 4, 2024 Risk: low
  CervoMed Inc. filed an 8-K on April 4, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Diffusio
• CervoMed Inc. Files 8-K: Material Agreement & Equity Sales — Mar 28, 2024 Risk: medium
  CervoMed Inc. announced on March 28, 2024, that it entered into a material definitive agreement. The company also disclosed unregistered sales of equity securit
• CervoMed Inc. Files 8-K on Shareholder Nominations — Mar 18, 2024 Risk: medium
  CervoMed Inc. filed an 8-K on March 18, 2024, reporting shareholder nominations pursuant to Exchange Act Rule 14a-11 and financial statements. The company, form
• CervoMed Inc. Files 8-K for Regulatory Updates — Mar 5, 2024 Risk: low
  CervoMed Inc. filed an 8-K on March 5, 2024, to report on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific
• CervoMed Reports Material Agreement & Security Holder Rights Modifications — Feb 28, 2024 Risk: medium
  CervoMed Inc. filed an 8-K on February 28, 2024, reporting an entry into a Material Definitive Agreement and Material Modifications to Rights of Security Holder
• CervoMed Files Routine 8-K; No Major Corporate Changes Reported — Feb 7, 2024
  CervoMed Inc. filed an 8-K on February 7, 2024, reporting an event that occurred on February 5, 2024. This filing is a standard current report, indicating no ma
• CervoMed 8-K: Material Agreement & Officer Changes on Feb 1 — Feb 2, 2024
  CervoMed Inc. filed an 8-K on February 2, 2024, reporting events from February 1, 2024, related to an entry into a material definitive agreement and changes in
• CervoMed Files Administrative 8-K; No Major News — Jan 5, 2024
  CervoMed Inc. filed an 8-K on January 5, 2024, to report an "Other Event" and provide "Financial Statements and Exhibits." This filing primarily serves to updat
• CervoMed Inc. Files Routine 8-K, Confirms Corporate Details — Jan 4, 2024
  CervoMed Inc. filed an 8-K on January 4, 2024, primarily to disclose its current corporate information, including its business address at 20 Park Plaza, Suite 4

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX